Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
18/06/2020 6:24 am
Bloodwork question about tirzepatide. Baseline, four months in, and the numbers moved in a direction I did not expect.
The measured outcome and the hoped-for outcome are rarely the same thing in these threads.
Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.
Baseline first. Without a baseline the after picture is decoration.
What the GLP-1 class does pharmacologically does not require the subjective effect to be large to be real.
Curious whether the popular dose has any basis or is just the convenient one.
18/06/2020 7:23 am
Where does the human data stop and the extrapolation begin? That is the whole thread.